share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director WADDELL FREDERICK H

SEC announcement ·  May 8 06:31
Summary by Futu AI
On May 3, 2024, Frederick H. Waddell, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. Following this transaction, Waddell's direct holdings in the company increased to a total of 27,755 shares. The grant, which is part of the company's compensation or incentive program, reflects AbbVie's ongoing commitment to align the interests of its executives with those of its shareholders. The transaction was completed successfully, with no subsequent sales reported.
On May 3, 2024, Frederick H. Waddell, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. Following this transaction, Waddell's direct holdings in the company increased to a total of 27,755 shares. The grant, which is part of the company's compensation or incentive program, reflects AbbVie's ongoing commitment to align the interests of its executives with those of its shareholders. The transaction was completed successfully, with no subsequent sales reported.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.